<code id='BD122B5844'></code><style id='BD122B5844'></style>
    • <acronym id='BD122B5844'></acronym>
      <center id='BD122B5844'><center id='BD122B5844'><tfoot id='BD122B5844'></tfoot></center><abbr id='BD122B5844'><dir id='BD122B5844'><tfoot id='BD122B5844'></tfoot><noframes id='BD122B5844'>

    • <optgroup id='BD122B5844'><strike id='BD122B5844'><sup id='BD122B5844'></sup></strike><code id='BD122B5844'></code></optgroup>
        1. <b id='BD122B5844'><label id='BD122B5844'><select id='BD122B5844'><dt id='BD122B5844'><span id='BD122B5844'></span></dt></select></label></b><u id='BD122B5844'></u>
          <i id='BD122B5844'><strike id='BD122B5844'><tt id='BD122B5844'><pre id='BD122B5844'></pre></tt></strike></i>

          fashion

          fashion

          author:focus    Page View:5727
          One Medical and Amazon Care apps displayed on a phone. -- health tech coverage from STAT.
          Adobe

          The graveyard is littered with Amazon’s bets in health care: wearables, Care, the ill-fated Haven. Out of their ashes, a new health strategy has emerged at the tech goliath. And while its leaders insist that Amazon has no grand plan for health care, a flurry of moves in the last year offer a glimpse into its ambitions at a time when they seem more cohesive than ever.

          “We have learned a lot in the years that we’ve been dabbling in health care,” said Sunita Mishra, chief medical officer for Amazon Health Services. “And it’s now made us more confident that we’re on the right track.”

          advertisement

          STAT spoke to four of Amazon’s chief medical officers about the company’s recent plays and how they fit into the company’s health care goals. Last November, it launched Amazon Clinic, a marketplace for virtual-only appointments for straightforward medical needs like pink eye, UTIs, and birth control. Two months later, its Amazon Pharmacy business launched RxPass, a $5 generic medication discount program, setting it up as a Walmart rival. And in February, it closed the acquisition of hybrid primary care company One Medical in a deal valued at $3.9 billion.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Australia's humpback populations rebound raising hopes of marine scientists
          Australia's humpback populations rebound raising hopes of marine scientists

          0:50AhumpbackwhalebreachesnearSydney,Australia,June24,2023.CourtesyMarkWongJulymarksthepeakofthehump

          read more
          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more

          How to pay for weight loss drugs and save Medicare

          CydniElledge/TheNewYorkTimesThenewsaboutanti-obesitydrugskeepsgettingbetter.InNovember,datapresented